The proinflammatory cytokine tumor necrosis factor-alpha (TNF-a) inhibits normal keratinocytes proliferation. However, many human papillomavirus (HPV)-immortalized or transformed cell lines are resistant to TNF-a antiproliferative effect. The present study analyzes the effects of TNF-a on organotypic cultures of primary human keratinocytes (PHKs) that express HPV-18 oncogenes. Raft cultures prepared with PHKs acutely transfected with HPV-18 whole genome or infected with recombinant retroviruses containing only E6/E7 or E7 were treated with 2 nM TNF-a. While BrdU incorporation into basal/parabasal cells of normal PHKs cultures was markedly inhibited by TNF-a cultures transfected with HPV-18 whole genome showed proliferation in all cell strata. Furthermore, BrdU incorporation into cultures expressing E6/E7 or E7 was not significantly reduced, indicating that E7 alone confers partial resistance to TNF-a. Besides, TNF-a treatment did not alter p16 ink4a , p21 cip1 , p27 kip1 , or cyclin E levels, but did reduce cyclin A and PCNA levels in sensitive cells.
Introduction
Human papillomaviruses (HPVs) are small DNA viruses that show a high degree of tropism for cutaneous and mucosal squamous epithelial cells. Individual HPV types display specificities for both the anatomic site and the histopathology of the associated lesions. Mucosal HPVs preferentially infect the genital tract, causing warts and condylomas that usually regress. Such infections are common in sexually active individuals. However, a small percentage of women who are persistently infected with oncogenic genotypes, such as , develop high-grade dysplasias and cervical cancer (Bosch et al., 2002; Ho et al., 1995; Kadish et al., 1997; Remmink et al., 1995; Schlecht et al., 2001) . In productive infections, the viral DNA replicate as extrachromosomal plasmids in differentiated keratinocytes in which S phase is reactivated by the viral oncogene E7. In contrast, in malignant lesions, the oncogenic HPV genome frequently integrates into the host DNA, and E6 and E7 are expressed at elevated levels in basal/parabasal cells relative to benign lesions in which their expression is below the sensitivity of in situ detection (Chow and Broker, 1997a) .
The ability of E6 and E7 proteins to bind and induce the degradation of p53 and pRb tumor suppressor proteins, respectively, is not only critical for viral replication, but is also central to the malignant potential of these viruses (Mü nger and Howley, 2002 vitro (Fehrmann and Laimins, 2003) . Moreover, transfection of normal human keratinocytes with recombinant HPV DNA of oncogenic types causes low-grade dysplasias when inoculated into athymic mice (Woodworth et al., 1990) or grown in organotypic raft cultures (McCance et al., 1988; Steenbergen et al., 1998) . The continuous expression of these proteins is required for maintaining the transformed phenotype, as repression of E6 and E7 in HeLa cells causes the reactivation of p53 and pRb tumor suppressor pathways, leading to either apoptosis or senescence (DeFilippis et al., 2003; Francis et al., 2000; Goodwin and DiMaio, 2000) .
The host immune surveillance plays an important role in controlling HPV infections. In immunocompetent hosts, viral infection causes the production and release of several cytokines from macrophages, NK cells, lymphocytes, fibroblasts, and keratinocytes. Many of these cytokines, such as TNF-a, IL-1, interferon-a, -h, and -g, downregulate HPV early gene expression and retard the growth of cell lines harboring the viral genome (Kim et al., 2000a; Kyo et al., 1994; Pao et al., 1995) . Among them, TNF-a is one of the main mediators of inflammation in the skin and mucosa, the first barrier encountered by an epitheliotropic virus. This cytokine binds to cell surface receptors, TNFR1 and TNFR2 , that are members of the TNF receptor superfamily (Smith et al., 1994) . Ligand binding induces receptor trimerization and initiates various signaling pathways that lead to growth arrest, cell proliferation, differentiation, or apoptosis (Nagata, 1997) . The response to TNF-a depends on the specific ligand-receptor interaction, as well as the cell type and microenvironment (Wallach et al., 1999) . TNFR1 activation by TNF-a has been associated with signaling pathways involved in antiviral activities, cytotoxicity, activation of transcription factors, and cell death (Tartaglia et al., 1993; Wong et al., 1992) .
Several lines of evidence suggest that immune effector mechanisms against HPV-infected cells may indeed include direct or indirect participation of TNF-a. Apoptosis and spontaneous regression of papillomas correlate with high level of expression of this cytokine in infiltrating mononuclear cells (Hagari et al., 1995) . In vitro studies have shown that TNF-a is a potent inhibitor of normal human keratinocyte proliferation. In these cells, the cyclin-dependent kinase inhibitor p21 CIP1 is activated through nuclear factor-nB (NF-nB) and is an important mediator of this growth arrest response (Basile et al., 2003) . On the other hand, HPV-18 and SV40 immortalized keratinocytes as well as HPV-16 or -18 transformed keratinocytes are resistant to the antiproliferative effect of TNF-a (Vieira et al., 1996; Villa et al., 1992) . Moreover, transfection of HPV-16 E6 into TNF-a sensitive mouse fibroblast LM cells protects them from TNF-induced apoptosis (Duerksen-Hughes et al., 1999) and HPV-16 E7 overcomes TNF-a-mediated growth arrest and induction of differentiation in submerged cultures of keratinocytes (Basile et al., 2001) . It has been also observed that E7 interferes with NF-nB activation upon treatment with TNF-a, and does so through attenuation of the InB kinase a activity (IKKa) (Spitkovsky et al., 2002) . Studies involving nontumorigenic somatic-cell hybrids between the cervical carcinoma-derived HPV-18 positive cell line HeLa and normal human fibroblast have shown that treatment with TNF-a down-regulates HPV gene transcription and induces the MCP-1 (monocyte chemoattractant protein-1) factor. Significantly, none of these effects was observed in tumorigenic hybrids segregants Soto et al., 1999 . Thus, it seems that the acquisition of TNF-a resistance may be critical to HPV pathogenesis.
The issue whether HPV oncogenes can confer TNF-a resistance during squamous epithelial differentiation has not been examined in detail. In the present study, we have analyzed the effects of TNF-a on organotypic raft cultures of low-passage primary human keratinocytes (PHKs) after acute transduction with HPV-18 genome or HPV-18 oncogenes. The raft culture system faithfully recapitulate the HPV-host interactions observed in vivo (Chow and Broker, 1997b) . Besides, it simulates an S phase environment in which the negative regulation of host DNA replication is similar to that observed in productive infections (Jian et al., 1998 (Jian et al., , 1999 Noya et al., 2001 ). Our results show that HPV-18 E7 alone is able to confer at least partial resistance to TNF-a arrest of S phase entry. Furthermore, we show that whole genomic HPV18 DNA confers almost complete resistance to this cytokine, indicating that a role by additional viral factors in acquiring TNF-a resistance cannot be excluded. Immunofluorescence and Western blot analysis indicate that the inhibitory effect of TNF-a on PHKs does not involve an increase in the levels of CDK inhibitors such as p16 ink4a , p21 cip1 , or p27 kip1 , nor an alteration in cyclin E levels. However, it reduced the levels of cyclin A and proliferating cell nuclear antigen (PCNA) in cells sensitive to TNF-a.
Results

TNF-a differentially affects the histology of organotypic raft cultures of normal keratinocytes and keratinocytes expressing HPV genes
We compared the effects of TNF-a on normal raft cultures of early passages PHKs and on those acutely transfected with HPV-18 whole genome DNA or transduced with recombinant retroviruses containing HPV-18 URR-E7 or HPV-18 URR-E6/E7. The cultures were either untreated or treated on day 9 with 2 nM of TNF-a for 72 h and exposed to BrdU for the last 12 h before harvest on day 12. When untreated, normal raft cultures closely resembled normal epithelium in vivo with morphologically distinct basal, spinous, granular, and cornified layers. The cells tended to start to flatten at the mid spinous strata (Fig. 1a) . Untreated raft cultures that contained HPV-18 genome, E6/E7 oncogenes, or E7 oncogene alone, were also fully differentiated with comparable strata. However, the spinous stratum, and occasionally the parabasal stratum as well, were thicker than the control cultures. In particular, many spinous and granular cells retained a large nucleus even when they reached the superficial stratum, just before they terminally differentiated into cornified squames (Figs. 1c, e, g ).
After treatment with TNF-a, normal raft cultures exhibited a flattened morphology in all cell layers (Fig.  1b) . The HPV-containing raft cultures had a reduced thickness relative to the untreated cultures, and they also had a more flattened morphology, but primarily in the basal keratinocytes. Again, many spinous and granular cells retained a large nucleus. These morphological alterations were consistently observed in all the raft cultures sections analyzed (Figs. 1d,f,h).
HPV-18 E7 confers resistance to TNF-a inhibition of S phase entry
We evaluated the effects of TNF-a on the proliferation of PHKs in organotypic cultures by immunohistochemistry. In the normal raft cultures, only basal/parabasal cells were positive for BrdU ( Fig. 2a ) and TNF-a markedly inhibited the proliferation of these cells. This is evident from the decrease in the number of cells in the basal layer that incorporate BrdU (Fig. 2b) .
Previous studies have demonstrated that HPV16 or HPV18 E7 alone induces host DNA synthesis in a fraction of otherwise nonproliferating, differentiated keratinocytes (Cheng et al., 1995; Flores et al., 2000; Jones et al., 1997; Ruesch and Laimins, 1997) . In the present study, BrdUpositive cells were observed in a subset of cells at all strata of raft cultures derived from PHKs transfected with the complete HPV18 genome or transduced with URR-E6/E7 or URR-E7 (Figs. 2c,e,g). Upon treatment with TNF-a, BrdU incorporation was reduced in cultures derived from normal PHKs (Fig. 2b) , while it remained unaltered in cultures containing HPV18 whole genome (Fig. 2h ). In the suprabasal strata, BrdU-positive nuclei were usually enlarged relative to BrdU-negative cells, in agreement with endoreduplication and polyploidy (Chien et al., 2002) . Besides, in the E6/E7 and E7 cultures, the number of BrdU-positive To quantify TNF-a effect on BrdU incorporation, the BrdUmarked/total nuclei ratio was determined by direct counting of BrdU-positive and -negative nuclei in all control and TNF-a treated cultures. These results are summarized in Fig. 3 and suggest that E7 expression alone is sufficient to partially overcome the sensitivity to TNF-a.
Expression of genes involved in cell cycle regulation
To identify molecular events that could explain the different responses of these raft cultures to TNF-a, expression of p21 cip1 and p27 kip1 proteins was examined along with BrdU incorporation by double immunofluorescence. p21 cip1 and p27 kip1 bind and inhibit cyclin E/cdk2 and cyclin A/cdk2, thereby preventing cells from entering the S phase (Sherr and Roberts, 1999) . In agreement with our previous studies (Chien et al., 2002; Jian et al., 1998; Noya et al., 2001) , no p21 cip1 protein was detected in raft cultures of normal keratinocytes (Fig. 4a) , nor in those Fig. 1 . BrdU incorporation was detected by immunohistochemical probing. To reveal tissue histology, sections were counterstained with hematoxylin. Fig. 3 . BrdU incorporation in raft cultures expressing HPV-18 genes is not affected by TNF-a. The BrdU-positive/total nuclei ratio was determined by direct counting cell nuclei under the microscope in three independent fields of untreated (light gray) or TNF-a treated (dark gray) raft culture sections (from the rafts shown in Fig. 1 ). The bars correspond to values obtained in at least two different experiments.
expressing the E6 protein of HPV-18 (data not shown; Jian et al., 1998) . In contrast, raft cultures of keratinocytes transduced with HPV-18 URR-E7 or URR-E6/E7 or those transfected with the entire HPV-18 genome presented a clear induction of this protein in a subset of suprabasal cells (Figs.  4c,e,g ). Interestingly, neither the signal intensity nor the distribution pattern of the p21 cip1 protein seemed to be altered by treatment with TNF-a in any of the organotypic cultures, suggesting that this CKI is not involved in the effects caused by this cytokine (Figs. 4b,d ,f,h). Expression of p27 kip1 was detected in some of the suprabasal layers of raft cultures from both normal keratinocytes and those expressing HPV-18 E7 gene. The same is observed in HPV warty lesions (Chien et al., 2002; Noya et al., 2001 ). The distribution of p27 kip1 was also mutually exclusive with that of BrdU incorporation as previously described (Figs. 5a, c, e, g ). The signal levels and distribution of this protein were not altered by TNF-a, indicating that the effects of this cytokine are also independent of p27 kip1 (Figs. 5b,d,f,h ).
For more quantitative information, we performed Western blot analysis using whole cell extracts of raft cultures for these two CKIs. The results are consistent with the in situ analyses as we detected little or no difference in raft culture with or without TNF-a treatment (Fig. 6a) . We then examined by Western blot the effects of TNF-a on the expression of other cell cycle regulatory proteins, including cyclin E, cyclin A, proliferating cell nuclear antigen (PCNA), and p16 ink4a . Cyclin E is required for S phase entry and is usually below detection by in situ methods in normal raft cultures but its level is abnormally high in E7-expressing, differentiated cells. This is because cyclin E/cdk2 is stabilized in kinase-inactive complexes with p27 kip1 or p21 cip1 (Jian et al., 1999; Noya et al., 2001 ). The analysis revealed that it was not modulated by treatment with TNF-a (Fig. 6b) .
Cyclin A and PCNA are required for S phase progression and DNA replication, respectively. After treatment with TNF-a, we observed a dramatic reduction in the levels of these two proteins only in the raft cultures derived from normal PHKs, which are sensitive to this cytokine. Furthermore, we observed a slight down-regulation of cyclin A in HPV-18 E7 or E6/E7 expressing cultures. On the other hand, there was no reduction in PCNA levels in extracts from raft cultures expressing HPV-18 E7 or E6/E7 genes or those containing the genomic HPV-18 DNA (Fig. 6a) . p16 ink4a inhibits the assembly of cyclin D/cdk4 or cdk6, which normally regulate pRB function (Graña and Reddy, 1995) . The regulation of these kinases by p16 ink4a is bypassed when pRB is inactivated by the oncogenic HPV E7 protein. Previous reports show that p16 ink4a accumulates in pRB-negative cells such as those expressing high-risk HPV E7 or in which this factor is inactivated by mutation (Doki et al., 1997; Kelley et al., 1995; Parry et al., 1995) . In our normal raft cultures, we detected no p16 ink4a protein (Fig. 6b) . On the other hand, raft cultures of keratinocytes containing the complete HPV-18 genome exhibited high levels of this protein as observed in Western blot assays using whole cell extracts. TNF-a treatment induced a slight decrease in p16 ink4a levels in raft cultures containing HPV-18 genome relative to the untreated counterpart.
Discussion
TNF-a is a proinflammatory cytokine that plays a key role in inflammatory and infectious diseases, especially in viral infections. This cytokine is produced by a wide variety of cells including activated macrophages, keratinocytes, monocytes, lymphocytes, and fibroblasts. It elicits a broad spectrum of cellular responses including proliferation, differentiation, and apoptosis ). It has been previously shown that HPV-18 immortalized and cervical carcinoma-derived cell lines are resistant to this cytokine (Vieira et al., 1996; Villa et al., 1992) . In this study, we demonstrated that in organotypic cultures of primary human keratinocytes, acute transduction and expression of HPV-18 oncogenes conferred resistance to growth inhibitory effects of TNF-a. These results indicate that TNF resistance does not depend on the acquisition of a fully immortalized or transformed HPVassociated phenotype.
We show that the basal cells of normal control raft cultures are highly sensitive to TNF-a. In contrast, raft cultures containing transfected HPV-18 genome or transduced with E6/E7 oncogene(s) or E7 alone were at least partially resistant to the inhibitory effect of TNF-a. On the other hand, transduction of PHKs with retroviruses containing HPV 18 URR-E6 failed to induce S phase reentry in suprabasal cells of organotypic cultures as previously observed (data not shown; Cheng et al., 1995) . However, it was able to partially overcome the inhibitory effect of TNF-a in the basal cells (our unpublished observation) where a low level of E6 expression is expected. Resistance to TNF-a effects mediated by E6 has been previously reported. It has been observed that this oncoprotein is capable of binding to TNF receptor 1 and protect mouse fibroblasts, human osteosarcoma cells, and human histiocyte/monocyte cells from TNF-a-mediated apoptosis (Filippova et al., 2002) . Furthermore, it has been shown that E6 can down-regulate IL-8 expression in human keratinocytes by competing with NF-nB/p65 and steroid receptor co-activator 1 (SRC-1) for binding to the N terminus and C terminus of the transcriptional activator CPB, respectively (Huang and McCance, 2002) .
The complete genome appeared to be more effective in conferring TNF-a resistance. There are at least two possible explanations for this enhanced resistance by cells containing the whole HPV-18 genomic DNA. First, it could be attributed to the ability of the intact genome to amplify and increase the E7 and E6 gene dosage relative to the low copy number of retrovirus-transduced E7 gene. This interpretation is in agreement with the observation that BrdU incorporation in raft cultures derived from PHKs acutely transfected with a replication-defective HPV-16 genome was inhibited by TNF-a, because the nonreplicating viral DNA was lost during cell division (data not shown). The second possibility is that viral genes, other than E6 and E7, also play a role. Currently, we do not know what cause the HPV-containing raft cultures to become thinner. There are two possibilities that are not mutually exclusive. One is that the basal cells, where little E6 or E7 is expressed, were partially sensitive to TNF-a. The second is that TNF-a is able to speed up terminal differentiation of the cells in the upper strata.
Previous reports by Delvenne et al. (1995 Delvenne et al. ( , 2001 ) have shown that TNF-a, alone or in combination with interferong, was able to inhibit the growth of normal and HPVtransformed keratinocytes in monolayer and organotypic cultures. The experiments described by these authors differ from those in the present study in at least two aspects. First, they describe the effect of TNF-a on organotypic cultures obtained from HPV-transformed cell lines derived from cervical carcinomas (SiHa, CasKi, C4-II). Similar results, using monolayer cultures, were also previously published by us (Villa et al., 1992; Vieira et al., 1996) . In the present study, we show that acute expression of HPV-18 E7 in earlypassage keratinocytes confers resistance to TNF-a previous to the onset of a fully immortalized phenotype. This observation indicates that TNF-a resistance is an early step in HPV pathogenesis. Second, in the experiments performed by Delvenne et al. (1995 Delvenne et al. ( , 2001 ), TNF-a was present along the whole organotypic culture duration. As observed by the authors, this treatment inhibited not only normal keratinocytes proliferation but the onset of normal epithelial stratification. This could be a consequence of early exposure of keratinocytes to the cytokine. In our study, TNF-a treatment was reduced to the last 72 h of culture, when keratinocyte organotypic cultures already display the morphology of normal epithelium with discrete basal, spinous, granular, and cornified cell layers.
Among the cell cycle regulatory proteins investigated, only cyclin A and PCNA that function during S phase are down-regulated in TNF-a-sensitive cells. However, we do not know whether this is the cause or the consequence of growth arrest.
Our results in the raft cultures agree with recent studies showing that HPV-16 E7 is capable of overcoming the antiproliferative effect of this cytokine in monolayer cultures of human keratinocytes (Basile et al., 2001 ). However, in that case, the level of p21 cip1 protein was observed to increase by Western blots. In contrast, our Western blots and in situ investigations did not reveal any increase in the levels or distribution of the p21 cip1 protein in the normal PHK raft culture, which is sensitive to TNFa, nor in raft cultures expressing HPV-18 E7 oncoprotein, which are at least partialy resistant to this cytokine. The p21 cip1 protein is expressed at or below the sensitivity of detection in normal raft cultures. Its transcription is upregulated in the differentiated keratinocytes but the protein is only stabilized in a fraction of the post-mitotic suprabasal keratinocytes expressing the E7 gene of HPV 18, leading to an inhibition of DNA synthesis induced by the viral oncoprotein (Chien et al., 2002; Jian et al., 1998 Jian et al., , 1999 Noya et al., 2001) . The stabilization of p21 cip1 protein in differentiated keratinocytes expressing HPV-18 E7 is caused by co-stabilization and co-accumulation in a complex with cdk2 and cyclin E induced by E7. In agreement, we observed p21 cip1 and cyclin E up-regulation in rafts expressing HPV-18 E7, E6/E7, and HPV genome. However, TNF-a treatment did not affect the levels and distribution of p21 cip1 along the different cell layers. Consequently, the level of the co-stabilized cyclin E was not altered.
Interestingly, the effects of TNF-a on the expression of p27 kip1 appear to depend on the cell type studied. For example, TNF-a activates the expression of p27 kip1 in bone marrow macrophages (Okahashi et al., 2001 ). On the other hand, in the absence of growth factors, TNF-a stimulates the proliferation of HPV-immortalized keratinocyte cell lines (Woodworth et al., 1995) , and this effect is mediated, in part, by the decrease of p27 kip1 levels (Gaiotti et al., 2000) . The importance of the decrease in levels of the p27 kip1 protein on the pathogenesis by HPV has been proposed based on studies of cervical cancers (Kim et al., 2000b; Saito et al., 1999; Skomedal et al., 1999) . p27 kip1 , unlike p21 cip1 , is stably expressed during squamous differentiation and continue to increase in the upper strata in normal raft cultures. In raft cultures that express HPV-18 E7 oncogene, the pattern of p27 kip1 distribution was not altered and high levels of p27 kip1 inhibits S phase reentry, because it sequesters cyclin E/cdk2, as does p21 cip1 (Noya et al., 2001) . In the present study, we observed no alteration in the distribution or level of p27 kip1 protein upon treatment with TNF-a in the control or any of the E7-expressing raft cultures. Thus, in vivo, decrease in the p27 kip1 protein reported by others appears to be a late event during evolution of the lesions, rather than a direct effect of the viral oncogenes.
Cell cycle progression is also regulated by p16 ink4a , which inhibits cdk4 and cdk6 (Graña and Reddy, 1995) . Nakao et al. (1997) described the induction of p16 ink4a in cells immortalized by HPV16 and 18. Furthermore, several epidemiological studies reported an increase in p16 ink4a levels in cervical cancers, as well as an association of these alterations with the HPV type present in the lesions (Klaes et al., 2001; Park et al., 1999; Sano et al., 1998) . Moreover, an association between HPV infection, p16 ink4a levels, and oral carcinomas has also been described (Saito et al., 1999) . Our findings indicate that the induction of p16 ink4a production is an acute response to the introduction of HPV-18. This is in agreement with observations in lesions produced by high-risk HPVs (Klaes et al., 2001) . Interestingly, we observed a small decrease in the levels of p16 ink4a following treatment with TNF-a. The mechanism by which TNF-a inhibits the expression of p16 ink4a is not known, but the implications may be important as the ink4 family of proteins inhibit the activity of NF-nB (Wolff and Naumann, 1999) , an important mediator of the antiproliferative effects of TNF-a in keratinocytes (Chaturvedi et al., 1999; Hu et al., 2001; Komine et al., 2000; Seitz et al., 2000; Soto et al., 2000; van Hogerlinden et al., 1999) .
In conclusion, our results show that HPV-18 gene expression confers resistance to TNF-a antiproliferative effect in raft cultures of acutely transduced primary human keratinocytes. Furthermore, we describe, for the first time, that expression of HPV-18 E7 driven from its natural promoter is sufficient to partially overcome the TNF-a effect. Moreover, our data indicate that HPV-18-induced resistance to TNF-a is an early event that takes place in the absence of a fully immortalized or transformed phenotype. We are currently examining the individual contributions of several E7 properties to the establishment of TNF-a resistance in PHKs. Understanding the HPV oncogenes-mediated mechanisms that modulate the effects of this cytokine in epithelial cells could be important in the control of HPV infection, lesion development, and tumor progression.
Materials and methods
Retroviruses, cells, and organotypic raft cultures
PHKs recovered from neonatal foreskins were grown in serum-free medium (Life Technologies, Inc., Rockville, MD), acutely infected with recombinant Moloney murine leukemia viruses or transfected with HPV 18 whole genome, and then used to seed the epithelial raft cultures without extensive passage as previously described (Cheng et al., 1995; Parker et al., 1997) . Recombinant retroviruses containing HPV-18 URR-E7 or HPV-18 URR-E6/E7 have been described elsewhere (Cheng et al., 1995) . These vectors express the bacterial neomycin resistance gene driven by the SV40 promoter, whereas the HPV gene or genes are under the control of the native HPV regulatory sequence and promoter (URR for upstream regulatory region). PHKs harboring the full-length HPV18 genome were obtained as described previously (Meyers et al., 1997) . Briefly, HPV18 DNA was excised from a pBR322 backbone using EcoRI. Five micrograms of the purified HPV genome and 500 ng of pEGFP-N1 plasmid that carries the neomycin-selectable marker were electroporated into second-passage PHKs. After 24 h, the cells were selected with 250 Ag/ml of G418 for 3 days. Surviving cells were amplified and stored in liquid nitrogen until further use. After 9 days at the medium-air interface, raft cultures were treated with 2 nM TNF-a (Roche Applied Science, Indianapolis, IN) for 72 h. BrdU was added at 50 Ag/ml for the last 12 h before harvesting by fixation in 10% buffered formalin, embedded in paraffin, and then cut into 4-Am sections.
Antibodies and chemicals
The primary monoclonal antibodies used for immunoblotting (1:1000 dilution in all cases) and in situ immunodetections include p16
INK4a (554070; Pharmingen, Franklin Lakes, NJ), p21 cip1 (OP64; Oncogene Research, Cambridge, MA; 1:25), p27 kip1 (NCL-p27; Novocastra, Newcastle upon Tyne, UK; 1:20), and BrdU (18-0103; Zymed Laboratories, San Francisco, CA.; 1:50).
Protein extraction and immunoblotting
After 12 days at the liquid-air interface, raft cultures were detached from the collagen matrix with a scalpel and frozen in liquid nitrogen. Two rafts were minced in a tissue grinder containing 200 Al of cold lysis buffer (50 mM HEPES [pH 7], 1 mM DTT, 250 mM NaCl, 4 mM EDTA, 10 mM ZnCl 2 , 0.5% NP-40) with proteases inhibitors (Completek, Roche Diagnostics, GR). After 5 min on ice, the tubes were centrifuged for 20 min at 10 000 Â g and 4 8C to separate the insoluble material. Protein concentrations were determined by the Bio-Rad protein assay (Bio-Rad Laboratories, Hercules, CA). Fifty micrograms of proteins were resolved by electrophoresis through sodium dodecyl sulfate-12% polyacrylamide gels and then transferred to polyvinylidene difluoride membranes (Amersham Pharmacia Biotech, UK) using semidry blotting techniques. The membranes were blocked for 1 h in 5% nonfat milk, probed for 1-2 h with the primary antibodies, and, after extensive washing, reprobed with horseradish peroxidase (HRP)-conjugated secondary antibodies. The bands were revealed using enhanced chemiluminescence procedures according to the manufacturer's recommendations (Amersham Pharmacia Biotech).
Immunohistochemical and immunofluorescence detection
Antigen retrieval was achieved by incubating deparaffinized sections in 10 mM citrate buffer (pH 6) at 95 8C for 10 min. Immunohistochemical detections of BrdU were performed using the primary antibody in conjunction with the Histostain-SP broad-spectrum kit following the manufacturer's instructions (Zymed Laboratories). The sections were then counterstained with hematoxylin. Images were captured with a SPOT digital camera (Diagnostic Instruments, Sterling Heights, MI) attached to an Olympus BH-2 microscope. For double immunofluorescence involving BrdU, the sections were treated for antigen retrieval, blocked, and then probed overnight with the monoclonal antibody to the protein antigen of interest (anti-p21 cip1 Ab-1, Oncogene Research; anti-p27 kip1 NCL-27, Novocastra). The sections were then washed with phosphate-buffered saline and reprobed with biotinylated anti-mouse immunoglobulin G (IgG). After washing, the sections were reacted with streptavidin-Texas Red (1:50, Vector Laboratories, Burlingame, CA), and probed with fluorescein-conjugated anti-BrdU antibody (1:50, Roche Biochemicals, GR). The images were captured with an Olympix 2000 digital camera (Life Sciences Resources, Cambridge, UK) attached to an Olympus Provis AX70 microscope. All images were digitally processed using Photoshop 6.0 (Adobe Systems, San Jose, CA).
